Chronic Respiratory Symptoms and Diseases Among Indigenous Children

Pediatric Clinics of North America

Volumn 56, Issue 6, 2009, Pages 1323-1342

  Redding, Gregory J ^a,b   Byrnes, Catherine A ^c  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b SEATTLE CHILDREN S HOSPITAL   (United States)

^c STARSHIP CHILDREN S HOSPITAL   (New Zealand)

Author keywords

Asthma; Bronchiectasis; Children; Cough; Indigenous; Wheeze

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; AZITHROMYCIN; BRONCHODILATING AGENT; CLARITHROMYCIN; CORTICOSTEROID; DEOXYRIBONUCLEASE; DORNASE ALFA; FENOTEROL; INFLUENZA VACCINE; IPRATROPIUM BROMIDE; MANNITOL; MONTELUKAST; PNEUMOCOCCUS VACCINE; SALBUTAMOL;

ASTHMA; ATELECTASIS; BRONCHIECTASIS; BRONCHITIS; CHRONIC RESPIRATORY TRACT DISEASE; CLINICAL TRIAL; COUGHING; HOSPITALIZATION; HUMAN; INDIGENOUS PEOPLE; LUNG DISEASE; NONHUMAN; PASSIVE SMOKING; PREVALENCE; RECURRENT DISEASE; REVIEW; SMOKING; SYMPTOM; WHEEZING;

ADOLESCENT; ASTHMA; BRONCHIECTASIS; CHILD; CHILD, PRESCHOOL; CHRONIC DISEASE; COUGH; EVIDENCE-BASED MEDICINE; FEMALE; HEALTH SERVICES, INDIGENOUS; HUMANS; INFANT; POPULATION GROUPS; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; PREVALENCE; RECURRENCE; RESPIRATORY SOUNDS; RESPIRATORY TRACT INFECTIONS; SMOKING; TOBACCO SMOKE POLLUTION;

EID: 72149104391     PISSN: 00313955     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pcl.2009.09.012     Document Type: Review

References (128)

1. Asher M.I., Montefort S., Bjorksten B., et al. Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAC phases one and three repeat multicountry cross-sectional surveys. Lancet 368 (2006) 733-743
2. World Health Organization. The World Health Organization Report (2005). http://www.who.int/whr/en Accessed July 2008
3. Peat J.K., and Veale A. Impact and aetiology of respiratory infections, asthma and airway disease in Australian Aborigines. J Paediatr Child Health 37 (2001) 108-112
4. Smylie J., and Adomako P. Indigenous children's health report: health assessment in action (2009), Centre for Research on Inner City Health, St. Michael's Hospital, Toronto
5. Zar H.J. Pneumonia in HIV-infected and HIV-uninfected children in developing countries: epidemiology, clinical features, and management. Curr Opin Pulm Med 10 (2004) 176-182
6. Orange C. The Treaty of Waitangi (1987), Allen and Unwin in association with Port Nicholson Press, Wellington, New Zealand
7. Walker R. Ka Whawhai Tonu Matou: Struggle without end (1990), Penguin Books, Auckland, New Zealand
8. Australian Bureau of Statistics. Population distribution, aboriginal and Torres Strait Islander Australians; 4705.02006.
9. Statistics New Zealand. QuickStats about Maori. Census 2006 (2007), Statistics New Zealand, Wellington, New Zealand
10. Statistics Canada. Aboriginal peoples in Canada in 2006: Inuit, Metis, and First Nations, 2006 Census (2008), Ministry of Industry, Ottawa, Canada Cat. No. 7-558-XIE. 2006
11. U.S. Census Bureau, Census Public Law. 94-171.
12. Statistics Canada. Aboriginal children's survey 2006. Catalogue number 89-634-XIE (2009), Statistics Canada, Ottawa, Canada
13. Robson B., Cormack D., and Cram F. Social and economic indicators: Hauora Maori standards of health IV (2007), Te Ropu Rangahau Hauora a Eru Pomare, Wellington, New Zealand
14. Australian Centre for Asthma Monitoring. Asthma in Australia (2008), Australian Institute of Health and Welfare, Canberra, Australia. http://www.aihw.gov.au/publications/index.cfm/title/10584 Accessed Mar 12, 09
15. Carville K.S., Lehmann D., Hall G., et al. Infection is the major component of the disease burden in aboriginal and non-aboriginal Australian children. Pediatr Infect Dis J 26 (2007) 210-216
16. Holman R.C., Curns A.T., Cheek J.E., et al. Infectious disease hospitalizations among American Indian and Alaska Native infants. Pediatrics 111 (2003) e176-e182
17. Moore H., Burgner D., Carville K., et al. Diverging trends for lower respiratory infections in non-aboriginal and aboriginal children. J Paediatr Child Health 43 (2007) 451-457
18. Grade Working Group. Education and debate-grading quality of evidence and strength of recommendations. BMJ 328 (2007) 1-8
19. Freemantle J., Officer K., McAullay D., et al. Australian Indigenous Health-Within an international context (2007), Darwin: Cooperative Research Centre for Aboriginal Health
20. Ross K. A Occasional paper: population issues, Indigenous Australia 1996. Australian Bureau of Statistics, Canberra. Cat. No. 4708.0; 1999.
21. Robson B., and Reid P. Ethnicity matters: Maori perspectives (2001), Statistics New Zealand, Wellington, New Zealand
22. Thomas D.R. Assessing ethnicity in New Zealand health research. N Z Med J 114 (2001) 86-88
23. Glasgow N.J., Goodchild E.A., Yates R., et al. Respiratory health in aboriginal and Torres Strait Islander children in the Australian Capital Territory. J Paediatr Child Health 39 (2003) 534-539
24. Harris S.B., Glazier R., Eng K., et al. Disease patterns among Canadian aboriginal children. Can Fam Physician 44 (1998) 1869-1877
25. Hemmelgarn B., and Ernst P. Airway function among Inuit primary school children in far northern Quebec. Am J Respir Crit Care Med 156 (1997) 1870-1875
26. Lewis T.C., Stout J.W., Martinez P., et al. Prevalence of asthma and chronic respiratory symptoms among Alaska Native children. Chest 125 (2004) 1665-1673
27. Poulos L.M., Toelle B.G., and Marks G.B. The burden of asthma in children: an Australian perspective. Paediatr Respir Rev 6 (2005) 20-27
28. Shaw R., Woodman K., Crane J., et al. Risk factors for asthma symptoms in Kawerau children. N Z Med J 12 (1994) 387-391
29. Valery P.C., Torzillo P.J., Mulholland K., et al. Hospital-based case-control study of bronchiectasis in indigenous children in Central Australia. Pediatr Infect Dis J 23 (2004) 902-908
30. Torzillo P.J., Hanna J.N., Morey F., et al. Invasive pneumococcal disease in central Australia. Med J Aust 162 (1995) 182-186
31. Singleton R.J., Holman R.C., Cobb N., et al. Asthma hospitalizations among American Indian and Alaska Native people and for the general US population. Chest 130 (2006) 1554-1562
32. Castro-Rodriguez J.A., Daszenies C., Garcia M., et al. Adenovirus pneumonia in infants and factors for developing bronchiolitis obliterans: a 5-year follow-up. Pediatr Pulmonol 41 (2006) 947-953
33. Colom A.J., Teper A.M., Vollmer W.M., et al. Risk factors for the development of bronchiolitis obliterans in children with bronchiolitis. Thorax 61 (2006) 503-506
34. Edwards E.A., Asher M.I., and Byrnes C.A. Paediatric bronchiectasis in the twenty-first century: experience of a tertiary children's hospital in New Zealand. J Paediatr Child Health 39 (2003) 111-117
35. Singleton R., Morris A., Redding G., et al. Bronchiectasis in Alaska Native children: causes and clinical courses. Pediatr Pulmonol 29 (2000) 182-187
36. Singleton R.J., Redding G.J., Lewis T.C., et al. Sequelae of severe respiratory syncytial virus infection in infancy and early childhood among Alaska Native children. Pediatrics 112 (2003) 285-290
37. Stein R.T., Sherrill D., Morgan W.J., et al. Respiratory syncytial virus in early life and risk of wheeze and allergy by age 13 years. Lancet 354 (1999) 541-545
38. Schel M.A., Hessen J.O., Smith K.R., et al. Childhood asthma and indoor woodsmoke from cooking in Guatemala. J Expo Anal Environ Epidemiol 14 (2004) s110-s117
39. Torres-Duque C., Maldonado D., Perez-Padilla R., et al. Biomass fuels and respiratory diseases: a review of the evidence. Proc Am Thorac Soc 5 (2008) 577-590
40. Anderson H.R., and Pounce de Leon A. Air pollution and daily mortality in London: 1987-1992. Br Med J 312 (1996) 665-669
41. Bates D.V. The effects of air pollution on children. Environ Health Perspect 103 (1995) 49-53
42. Aunan K. Exposure -response functions for health effects of air pollutants based on epidemiological findings. Risk Anal 16 (1996) 693-709
43. Braun-Fahriander C., Vuille J.C., Sennhauser F.H., et al. Respiratory health and long-term exposure to air pollutants in Swiss schoolchildren. SCARPOL Team. Swiss study on childhood allergy and respiratory symptoms with respect to air pollution, climate and pollen. Am J Respir Crit Care Med 155 (1997) 1042-1049
44. Dockery D.W., and Speizer F.E. Effects of inhaled particles on respiratory health of children. Am Rev Respir Dis 139 (1989) 587-594
45. Jaakkola J.J., Paunio M., Virtanen M., et al. Low-level air pollution and upper respiratory infections in children. Am J Public Health 82 (1991) 896-897
46. Nicolai T. Air pollution and respiratory disease in children: what is the clinically relevant impact?. Pediatr Pulmonol Suppl 18 (1999) 9-13
47. Ostro B., Broadwin R., Green S., et al. Fine particulate air pollution and mortality in nine California counties: results from CALFINE. Environ Health Perspect 114 (2006) 29-33
48. Dewailly E., Nantel A., Bruneau S., et al. Breast milk contamination by PCDDs, PCDFs and PCBs in Arctic Quebec: a preliminary assessment. Chemosphere 25 (1992) 1245-1279
49. Van Oostdam J., Donaldson S.G., Feeley M., et al. Human health implications of environmental contaminants in Arctic Canada: a review. Sci Total Environ 351-352 (2005) 165-246
50. McLeod D., Pullon S., and Cookson T. Factors that influence changes in smoking behaviour during pregnancy. N Z Med J 116 (2003) 1-8
51. Phares T.M., Morrow B., Lansky A., et al. Surveillance for disparities in maternal health-related behaviors-selected states, Pregnancy Risk Assessment Monitoring System (PRAMS), 2000-2001. MMWR Surveill Summ 53 (2004) 1-13
52. Scott S., Fogarty C., Day S., et al. Smoking rates among American Indian women giving birth in Minnesota. A call to action. Minn Med 88 (2005) 44-49
53. Tong V.T., Jones J.R., Dietz P.M., et al. Trends in smoking before, during, and after pregnancy-Pregnancy Risk Assessment Monitoring System (PRAMS), United States, 31 sites, 2000-2005. MMWR Surveill Summ 58 (2009) 1-29
54. Wills R.A., and Coory M.D. Effect of smoking among indigenous and non-indigenous mothers on preterm birth and full-term low birthweight. Med J Aust 189 (2008) 490-494
55. Stocks J., and Dezateux C. The effect of parental smoking on lung function and development during infancy. Respirology 8 (2003) 266-285
56. Scragg R., and Glover M. Parental and adolescent smoking: does the association vary with gender and ethnicity?. N Z Med J 120 (2007) 1-11
57. Sin D.D., Sharpe H.M., Cowie R.L., et al. Spirometric findings among school-aged First Nations children on a reserve: a pilot study. Can Respir J 11 (2004) 45-48
58. Landau L.I. Parental smoking: asthma and wheezing illnesses in infants and children. Paediatr Respir Rev 2 (2001) 202-206
59. Peat J.K., Keena V., Harakeh Z., et al. Parental smoking and respiratory tract infections in children. Paediatr Respir Rev 2 (2001) 207-213
60. Forster J.L., Brokenleg I., Rhodes K.L., et al. Cigarette smoking among American Indian youth in Minneapolis-St. Paul. Am J Prev Med 35 (2008) 449-456
61. Retnakaran R., Hanley A.J., Connelly P.W., et al. Cigarette smoking and cardiovascular risk factors among aboriginal Canadian youths. CMAJ 11 (2005) 885-889
62. Rempel G.R., Borton B.L., and Kumar R. Aspiration during swallowing in typically developing children of the First Nations and Inuit in Canada. Pediatr Pulmonol 41 (2006) 912-915
63. Marchant J.M., Masters I.B., Taylor S.M., et al. Utility of signs and symptoms of chronic cough in predicting specific cause in children. Thorax 61 (2006) 694-698
64. Donnelly D., Critchlow A., and Everard M.L. Outcomes in children treated for persistent bacterial bronchitis. Thorax 62 (2007) 80-84
65. Marchant J.M., Gibson P.G., Grissell T.V., et al. Prospective assessment of protracted bacterial bronchitis: airway inflammation and innate immune activation. Pediatr Pulmonol 43 (2008) 1092-1099
66. Chang A.B., Redding G.J., and Everard M.L. Chronic wet cough: protracted bronchitis, chronic suppurative lung disease and bronchiectasis. Pediatr Pulmonol 43 (2008) 519-531
67. Chang C.C., Singleton R.J., Morris P.S., et al. Pneumococcal vaccines for children and adults with bronchiectasis. Cochrane Database Syst Rev 2 (2009) CD006316
68. Kolbe J., and Wells A.U. Bronchiectasis: a neglected cause of respiratory morbidity and mortality. Respirology 1 (1996) 221-225
69. Twiss J., Metcalfe R., Edwards E., et al. New Zealand national incidence of bronchiectasis "too high" for a developed country. Arch Dis Child 90 (2005) 737-740
70. Massie R.J., Olsen M., Glazner J., et al. Newborn screening for cystic fibrosis in Victoria: 10 years' experience (1989-1998). Med J Aust 172 (2000) 584-587
71. Redding G., Singleton R., Lewis T., et al. Early radiographic and clinical features associated with bronchiectasis in children. Pediatr Pulmonol 37 (2004) 297-304
72. Redding G.J. Bronchiectasis in children. Pediatr Clin North Am 56 (2009) 157-171
73. Bush A., and Rubin B.K. Macrolides as biological response modifiers in cystic fibrosis and bronchiectasis. Semin Respir Crit Care Med 24 (2003) 737-747
74. Cymbala A.A., Edmonds L.C., Bauer M.A., et al. The disease-modifying effects of twice-weekly oral azithromycin in patients with bronchiectasis. Treat Respir Med 4 (2005) 117-122
75. Koh Y.Y., Lee M.H., Sun Y.H., et al. Effect of roxithromycin on airway responsiveness in children with bronchiectasis: a double-blind, placebo-controlled study. Eur Respir J 10 (1997) 994-999
76. Yalcin E., Kiper N., Ozcelik U., et al. Effects of claritromycin on inflammatory parameters and clinical conditions in children with bronchiectasis. J Clin Pharm Ther 31 (2006) 49-55
77. Cole P.J., Roberts D.E., Davies S.F., et al. A simple oral antimicrobial regimen effective in severe chronic bronchial suppuration associated with culturable Haemophilus influenzae. J Antimicrob Chemother 11 (1983) 109-113
78. Redding G.J., Kishioka C., Martinez P., et al. Physical and transport properties of sputum from children with idiopathic bronchiectasis. Chest 134 (2008) 1129-1134
79. O'Donnell A.E., Barker A.F., Ilowite J.S., et al. Treatment of idiopathic bronchiectasis with aerosolized recombinant human DNase I. rhDNase Study Group. Chest 113 (1998) 1329-1334
80. Daviskas E., Anderson S.D., Gomes K., et al. Inhaled mannitol for the treatment of mucociliary dysfunction in patients with bronchiectasis: effect on lung function, health status and sputum. Respirology 10 (2005) 46-56
81. Elkins M.R., Robinson M., Rose B.R., et al. A controlled trial of long-term inhaled hypertonic saline in patients with cystic fibrosis. N Engl J Med 354 (2006) 229-240
82. Furumoto A., Ohkusa Y., Chen M., et al. Additive effect of pneumococcal vaccine and influenza vaccine on acute exacerbation in patients with chronic lung disease. Vaccine 26 (2008) 4284-4289
83. Chang C.C., Morris P.S., and Chang A.B. Influenza vaccine for children and adults with bronchiectasis. Cochrane Database Syst Rev 3 (2007) CD006218
84. Corless J.A., and Warburton C.J. Leukotriene receptor antagonists for non-cystic fibrosis bronchiectasis. Cochrane Database Syst Rev 4 (2000) CD002174
85. Corless J.A., and Warburton C.J. Surgery versus non-surgical treatment for bronchiectasis. Cochrane Database Syst Rev 4 (2000) CD002180
86. Halfhide C., Evans H.J., and Couriel J. Inhaled bronchodilators for cystic fibrosis. Cochrane Database Syst Rev 4 (2005) CD003428
87. Kapur N., and Chang A.B. Oral non steroid anti-inflammatories for children and adults with bronchiectasis. Cochrane Database Syst Rev 4 (2007) CD006427
88. Zar H.J., Ehrlich R.I., Workman L., et al. The changing prevalence of asthma, allergic rhinitis and atopic eczema in African adolescents from 1995 to 2002. Pediatr Allergy Immunol 18 (2007) 560-565
89. Brim S.N., Rudd R.A., Funk R.H., et al. Asthma prevalence among US children in underrepresented minority populations: American Indian/Alaska Native, Chinese, Filipino, and Asian Indian. Pediatrics 122 (2008) e217-e222
90. Shaw R.A., Crane J., and O'Donnell T.V. Asthma symptoms, bronchial hyperresponsiveness and atopy in a Maori and European adolescent population. N Z Med J 8 (1991) 175-179
91. Liu L.L., Stout J.W., Sullivan M., et al. Asthma and bronchiolitis hospitalizations among American Indian children. Arch Pediatr Adolesc Med 154 (2000) 991-996
92. Ellison-Loschmann L., King R., and Pearce N. Regional variations in asthma hospitalisations among Maori and non-Maori. N Z Med J 30 (2004) U745
93. Williams H., Stewart A., von Mutius E., et al. Is eczema really on the increase worldwide?. J Allergy Clin Immunol 121 (2008) 947-954
94. Krause T., Koch A., Friborg J., et al. Frequency of atopy in the Arctic in 1987 and 1998. Lancet 360 (2002) 691-692
95. Redding G.J., Singleton R.J., DeMain J., et al. Relationship between IgE and specific aeroallergen sensitivity in Alaskan native children. Ann Allergy Asthma Immunol 97 (2006) 209-215
96. Epton M.J., Town G.I., Ingham T., et al. The New Zealand Asthma and Allergy Cohort Study (NZA2CS): assembly, demographics and investigations. BMC Public Health 7 (2007) 26
97. Chavasse R.J.P.G., Seddon P., Bara A., et al. Short acting beta2-agonists for recurrent wheeze in children under two years of age. Cochrane Database Syst Rev 2 (2002) CD002873
98. Bentur L., Canny G.J., Shields M.D., et al. Controlled trial of nebulized albuterol in children younger than 2 years of age with acute asthma. Pediatrics 89 (1992) 133-137
99. Chavasse R.J., Bastian-Lee Y., Richter H., et al. Inhaled salbutamol for wheezy infants: a randomised controlled trial. Arch Dis Child 82 (2000) 370-375
100. Clarke J.R., Aston H., and Silverman M. Delivery of salbutamol by metered dose inhaler and valved spacer to wheezy infants: effect on bronchial responsiveness. Arch Dis Child 69 (1993) 125-129
101. Fox G.F., Marsh M.J., and Milner A.D. Treatment of recurrent acute wheezing episodes in infancy with oral salbutamol and prednisolone. Eur J Pediatr 155 (1996) 512-516
102. Kraemer R., Frey U., Sommer C.W., et al. Short-term effect of albuterol, delivered via a new auxiliary device, in wheezy infants. Am Rev Respir Dis 144 (1991) 347-351
103. Kraemer R., Graf Bigler U., Casaulta Aebischer C., et al. Clinical and physiological improvement after inhalation of low-dose beclomethasone dipropionate and salbutamol in wheezy infants. Respiration 64 (1997) 342-349
104. Prahl P., Petersen N.T., and Hornsleth A. Beta 2-agonists for the treatment of wheezy bronchitis?. Ann Allergy 57 (1986) 439-441
105. Prendiville A., Green S., and Silverman M. Airway responsiveness in wheezy infants: evidence for functional beta adrenergic receptors. Thorax 42 (1987) 100-104
106. Everard M., Bara A., Kurian M., et al. Anticholinergic drugs for wheeze in children under the age of two years. Cochrane Database Syst Rev 3 (2005) CD001279
107. Mallol J., Barrueto L., Girardi G., et al. Use of nebulized bronchodilators in infants under 1 year of age: analysis of four forms of therapy. Pediatr Pulmonol 3 (1987) 298-303
108. Mallol J., Barrueto L., Girardi G., et al. Bronchodilator effect of fenoterol and ipratropium bromide in infants with acute wheezing: use of MDI with a spacer device. Pediatr Pulmonol 3 (1987) 352-356
109. Wang E.E., Milner R., Allen U., et al. Bronchodilators for treatment of mild bronchiolitis: a factorial randomised trial. Arch Dis Child 67 (1992) 289-293
110. Naspitz C.K., and Sole D. Treatment of acute wheezing and dyspnea attacks in children under 2 years old: inhalation of fenoterol plus ipratropium bromide versus fenoterol. J Asthma 29 (1992) 253-258
111. Henry R.L., Hiller E.J., Milner A.D., et al. Nebulised ipratropium bromide and sodium cromoglycate in the first two years of life. Arch Dis Child 59 (1984) 54-57
112. Brand P.L.P., Baraldi E., Bisgaard H., et al. Definition, assessment and treatment of wheezing disorders in preschool children: an evidence-based approach. Eur Respir J 32 (2008) 1096-1110
113. Bateman E.D., Hurd S.S., Barnes P.J., et al. Global strategy for asthma management and prevention: GINA executive summary. Eur Respir J 31 (2008) 143-178
114. Becker A., Lemiere C., Berube D., et al. Summary of recommendations from the Canadian Asthma Consensus Guidelines, 2003. CMAJ 173 (2005) S3-11
115. British Thoracic Society, and Scottish Intercollegiate Guidelines Network. British guideline on the management of asthma. Thorax 58 Suppl 1 (2003) i1-94
116. National Heart, Lung, and Blood Institute National Asthma Education and Prevention Program. Expert panel report 3: guidelines for the diagnosis and management of asthma (2007), National Heart, Lung and Blood Institute, Bethesda (MD)
117. Chang A.B., Shannon C., O'Neil M.C., et al. Asthma management in indigenous children of a remote community using an indigenous health model. J Paediatr Child Health 36 (2000) 249-251
118. Van Sickle D., and Wright A.L. Navajo perceptions of asthma and asthma medications: clinical implications. Pediatrics 108 (2001) E11
119. Bailey E., Cates C.J., Kruske S.G., et al. Culture-specific programs for children and adults from minority groups who have asthma. Cochrane Database Syst Rev 1 (2009) CD006580
120. Moudgil H., Marshall T., and Honeybourne D. Asthma education and quality of life in the community: a randomised controlled study to evaluate the impact on white European and Indian subcontinent ethnic groups from socioeconomically deprived areas in Birmingham, UK. Thorax 55 (2000) 177-183
121. Canino G., Vila D., Normand S.L., et al. Reducing asthma health disparities in poor Puerto Rican children: the effectiveness of a culturally tailored family intervention. J Allergy Clin Immunol 121 (2008) 665-670
122. La Roche M.J., Koinis-Mitchell D., and Gualdron L. A culturally competent asthma management intervention: a randomized controlled pilot study. Ann Allergy Asthma Immunol 96 (2006) 80-85
123. Chang A.B., Taylor B., Masters I.B., et al. Indigenous healthcare worker involvement for indigenous adults and children with asthma. Cochrane Database Syst Rev 4 (2007) CD006344
124. Substance Abuse and Mental Health Services Administration (SAMHSA). 2005 National survey on drug use and health: detailed tables (2007), USDHHS, Rockville (MD)
125. Stout J.W., Sullivan M., Liu L.L., et al. Asthma prevalence among American Indian and Alaska Native children. Public Health Rep 114 (1999) 257-261
126. Valery P.C., Purdie D.M., Chang A.B., et al. Assessment of the diagnosis and prevalence of asthma in Australian indigenous children. J Epidemiol 56 (2003) 629-635
127. First Nations Information Governance Committee. First Nations Regional Longitudinal Health Survey (RHS) 2002/03: results for adults, youth and children living in First Nations communities. 2nd edition (2007), Assembly of First Nations, Ottawa, Canada. http://www.rhs-ers.ca/english/pdf/rhs2002-03reports/rhs2002-03-technical report-afn.pdf Accessed February 28, 2009
128. Statistics Canada. The Health of Inuit Children: Report 2001. Inuit in Canada: Findings from the Aboriginal Peoples Survey-Survey of Living Conditions in the Arctic. Available at: http://www.statcan.gc.ca/bsolc/olc-cel/olc-cel?catno=89-627-XIE&lang =eng#Formatdisp.